High-throughput screening: rapid advancements in drug discovery
Listen to this podcast where we we explore the latest technological advancements in high throughput screening and more.
List view / Grid view
Listen to this podcast where we we explore the latest technological advancements in high throughput screening and more.
A 2D neuromuscular junction model enables high-throughput screening to discover new treatments for neuromuscular diseases.
Unleash the power of drug discovery with this FREE ebook supported by Sartorius! Explore the limitless potential of CRISPR applications and single cell sequencing for drug discovery. Access exclusive insights from industry leaders and stay ahead of the curve with the latest trends. Don't miss out on this opportunity to…
Oregon State University researchers have developed a screening model for rapid testing of multiple drug compounds, using a 3D cellular platform.
Matthew Lloyd from the University of Bath reveals the importance of the Z-factor and Z’-factor in high-throughput screening, and how they can be used to determine assay performance, perform quality control on the screen, and identify active compounds.
Transform your drug manufacturing process with the latest breakthroughs in technology. Effortlessly identify and differentiate degradation components of PS20 in protein-containing samples.
Tune into this podcast to hear experts discussing scaling up 3D organoids!
Tune into this podcast to hear experts discuss imaging and analysing data from organoids!
In this ebook are articles on how artificial intelligence can be used to identify drug candidates, data-lead screening models and autonomous strategies for molecular discovery.
Discover how picodroplet microfluidic technologies can identify and isolate 'hit' cells, quantify varying concentrations of antigen-specific antibodies and much more.
In the search for a rapid, easy way to identify drugs to fight SARS-CoV-2, researchers from across the US came together to develop and apply a high-throughput ADP-ribosylhydrolase assay, ADPr-Glo. Here, Dr Veronica Busa and Dr Anthony Leung from Johns Hopkins University describe the ADPr-Glo assay and how it can be…
Researchers have used a high-throughput assay to screen for potential small molecule SARS-CoV-2 replication inhibitors.
A report has shown that the immuno-oncology drug discovery outsourcing market is set to be worth $2563 million by 2030.
Researchers screened biologically active small molecules, finding several compounds with the ability to induce training effects on macrophages.
A bioluminescence resonance energy transfer sensor has been developed to report changes in intracellular Ca2+ concentrations during screening.